2016
The Effect of Vertical Versus Horizontal Vaginal Cuff Closure on Vaginal Length After Laparoscopic Hysterectomy
Hill AM, Davis KM, Clark-Donat L, Hammons LM, Azodi M, Silasi DA. The Effect of Vertical Versus Horizontal Vaginal Cuff Closure on Vaginal Length After Laparoscopic Hysterectomy. Journal Of Minimally Invasive Gynecology 2016, 24: 108-113. PMID: 27702701, DOI: 10.1016/j.jmig.2016.09.015.Peer-Reviewed Original ResearchMeSH KeywordsDyspareuniaFemaleHumansHysterectomyLaparoscopyMiddle AgedPostoperative ComplicationsProspective StudiesVaginaConceptsVaginal cuff closureLaparoscopic hysterectomyVaginal lengthCuff closureVaginal cuffTotal hysterectomyUniversity-affiliated community hospitalLaparoscopic total hysterectomyPOP-Q evaluationPostoperative vaginal lengthTotal laparoscopic hysterectomyPOP-Q scoresPOP-Q measurementsPelvic organ prolapseTraditional laparoscopic techniquePelvic floor proceduresRadical hysterectomyIntraoperative complicationsClosure groupLaparoscopic techniqueMalignant diseaseOrgan prolapseUterine manipulatorLaparoscopic closureCommunity hospital
2015
Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review
Roque DM, Ratner ES, Silasi DA, Azodi M, Rutherford TJ, Schwartz PE, Nelson WK, Santin AD. Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review. Gynecologic Oncology 2015, 137: 392-400. PMID: 25792179, DOI: 10.1016/j.ygyno.2015.03.008.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBevacizumabDisease-Free SurvivalDrug Administration ScheduleEpothilonesFallopian Tube NeoplasmsFemaleHumansMiddle AgedNeoplasm Recurrence, LocalOvarian NeoplasmsPeritoneal NeoplasmsProspective StudiesRetrospective StudiesConceptsObjective response rateFallopian tube cancerWeekly ixabepiloneOvarian cancerConcurrent bevacizumabRetrospective reviewMedian PFS/OSSimilar objective response ratesWarrants further prospective studySingle-institution retrospective reviewCA-125 criteriaPFS/OSTreatment of recurrentKaplan-Meier methodFurther prospective studiesBiweekly bevacizumabMedian PFSAcceptable toxicityGrade 1/2Median durationOverall survivalPrior linesClinical outcomesProspective studyUterine cancer